Healthcare industry reported 90 deals worth $25.7 billion in May 2021

In May 2021, the healthcare industry reported 90 deals worth $25.7 billion as compared to the last 12-month average (May 2020 to April 2021) of101 deals worth $22.4 billion.

Soaring Eagle Acquisition Corp, a special purpose acquisition company to acquire Ginkgo Bioworks, a biotech company for $15 billion; Nenelite Limited, an affiliate of Clayton, Dubilier & Rice, LLC to acquire UDG Healthcare plc, a provider of outsourced commercial solutions to healthcare companies for $3.9 billion; and Murano Bidco Limited, a company managed by Carlyle Europe Partners V to acquire Vectura Group plc, a formulation, device design and development company for $1.3 billion were the three major deals that contributed 78 per cent of the total deal value in May 2021.

VC investments decreased by 18.3 per cent in May 2021, compared to April 2021

The healthcare industry reported 147 venture capital (VC) deals worth $4.3billion in May 2021, compared to the last 12-month average (May 2020 to April 2021) of 155 deals worth $4.7 billion.

NiKang Therapeutics Inc, a clinical-stage biotech company, raising $200 million in series C financing to advance its lead drug candidates into the clinic, expand the pipeline and fund internal drug discovery program; Hangzhou DAC Biotech Co Ltd, raising $155.4 million in series C financing for R&D of ADC innovative drugs, clinical and optimization of its shareholding structure; and Eikon Therapeutics Inc, a drug discovery and development company, raising $148 million in series A round of financing to develop High-Throughput, Super-Resolution Microscopy for drug discovery were the major VC deals reported in May 2021.